Iovance Biotherapeutics (NASDAQ: IOVA) 报告称，季度每股亏损$(0.26)，好于分析师一致预期的$(0.27)，增幅为3.7%。 这比去年同期的$(0.45)每股亏损增加了42.22%。 公司报告的季度销售额为$7370万，好于分析师一致预期的$7239.3万，增幅为1.81%。 这比去年同期的$482.000千销售额增加了15.19千百分比。

以上内容来自Benzinga Earnings专栏，原文如下：

Iovance Biotherapeutics (NASDAQ:IOVA) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.27) by 3.7 percent. This is a 42.22 percent increase over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $73.700 million which beat the analyst consensus estimate of $72.393 million by 1.81 percent. This is a 15.19K percent increase over sales of $482.000 thousand the same period last year.